Literature DB >> 3020879

Thyroid function after postoperative radiation therapy in patients with breast cancer.

H Joensuu, J Viikari.   

Abstract

Thyroid stimulating hormone (S-TSH) and thyroxine (S-T4) were measured in sera from 80 patients with breast cancer using radioimmunoassay. The patients had been irradiated after mastectomy 7.2 +/- 1.0 years earlier with 45 Gy in 3 to 4 weeks to parasternal, ipsilateral supraclavicular and axillary areas. Five patients (6%) had hypothyroidism with low S-T4 and elevated S-TSH levels. In addition, 12 patients (15%) had elevated (greater than 5 mU/l) S-TSH levels and normal S-T4 values. Shielding of the thyroid during irradiation and long-term follow-up of thyroid function with repeated hormone assays are recommended.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020879     DOI: 10.3109/02841868609136397

Source DB:  PubMed          Journal:  Acta Radiol Oncol        ISSN: 0349-652X


  8 in total

1.  Evaluation of thyroid gland as an organ at risk after breast cancer radiotherapy: a systematic review and meta-analysis.

Authors:  L Darvish; M Ghorbani; S Hosseini Teshnizi; N Roozbeh; F Seif; M Reza Bayatiani; C Knaup; A Amraee
Journal:  Clin Transl Oncol       Date:  2018-05-14       Impact factor: 3.405

2.  Hypocalcemia due to osteoblastic metastases and diminished parathyroid reserve in a patient with advanced breast cancer.

Authors:  A Hermus; L Beex; P van Liessum; G Pieters; F Smedts; A Smals; P Kloppenborg
Journal:  Klin Wochenschr       Date:  1988-07-15

3.  Dose distribution in the thyroid gland following radiation therapy of breast cancer--a retrospective study.

Authors:  S Johansen; K V Reinertsen; K Knutstad; D R Olsen; S D Fosså
Journal:  Radiat Oncol       Date:  2011-06-09       Impact factor: 3.481

4.  Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  J Thyroid Res       Date:  2011-09-29

5.  Undetected hypothyroidism and unexpected anesthetic complications.

Authors:  P Sudha; Rachel Cherian Koshy; Viji S Pillai
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-04

6.  Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01).

Authors:  S de Groot; L G M Janssen; A Charehbili; E M Dijkgraaf; V T H B M Smit; L W Kessels; A van Bochove; H W M van Laarhoven; E Meershoek-Klein Kranenbarg; A E van Leeuwen-Stok; C J H van de Velde; H Putter; J W R Nortier; J J M van der Hoeven; H Pijl; J R Kroep
Journal:  Breast Cancer Res Treat       Date:  2015-01-04       Impact factor: 4.872

7.  Fast Model for Evaluation of the Thyroid Dosimetry During Chest Tumor Radiotherapy.

Authors:  Yiling Wang; Min Zheng; Ling He; Jinhui Xu; Gang Yin; Jie Zhou; Yue Zhao; Ming Jiang; Jie Wang
Journal:  Dose Response       Date:  2019-11-22       Impact factor: 2.658

8.  Prevalence of hypothyroidism among patients with breast cancer treated with radiation to the supraclavicular field: a single-centre survey.

Authors:  Yuichiro Kikawa; Yasuhiro Kosaka; Kazuki Hashimoto; Eri Hohokabe; Sayaka Takebe; Ryo Narukami; Takayuki Hattori; Kazuhiro Ueki; Kengo Ogura; Toshiyuki Imagumbai; Hironori Kato; Masaki Kokubo
Journal:  ESMO Open       Date:  2017-04-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.